Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application

Author(s): Toshio Nishikimi, Koichiro Kuwahara, Yasuaki Nakagawa, Kenji Kangawa, Kazuwa Nakao

Journal Name: Current Protein & Peptide Science

Volume 14 , Issue 4 , 2013

Become EABM
Become Reviewer
Call for Editor


Many neurohumoral factors play important roles in the regulation of the cardiovascular system and in the pathophysiology of cardiovascular disease. Adrenomedullin (AM) is a potent vasodilatory peptide originally discovered in the acid extract of human pheochromocytoma tissue but now known to exert a variety of effects within the cardiovascular system. AM expression is widely distributed throughout the cardiovascular system and has been identified in the heart, lungs, blood vessels and kidneys. In addition, the co-localization of AM and its receptor components suggest AM acts as an autocrine and/or paracrine factor to play a key role in the regulation of cardiovascular function. Evidence also strongly suggests that cardiovascular disease is associated with elevated levels of AM in plasma and tissue. In this review, we describe the pathophysiological changes in plasma and local AM associated with myocardial infarction, heart failure and pulmonary hypertension. We also describe the clinical application of AM in cardiovascular disease from the viewpoints of diagnosis and treatment.

Keywords: Adrenomedullin, myocardial infarction, heart failure, pulmonary hypertension, prognosis, ischemia/reperfusion.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 31 May, 2013
Page: [256 - 267]
Pages: 12
DOI: 10.2174/13892037113149990045
Price: $65

Article Metrics

PDF: 33